Acusphere, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACUS research report →
About the company
Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease.
- CEO
- William I. Ramage D.Phil
- IPO
- 2003
- Employees
- 50
- HQ
- Watertown, MA, US
Price Chart
- Market Cap
- $49
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.18
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- 1977.02%
- Net Margin
- -2014.62%
- ROE
- -130.75%
- ROIC
- 123.83%
- Revenue
- $2.67M · 49.75%
- Net Income
- $-53,730,000 · 12.05%
- EPS
- $-12.60 · 43.06%
- Op Income
- $52.73M
- FCF YoY
- 13.17%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.49
- Avg Volume
- 82.5
Get TickerSpark's AI analysis on ACUS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 25, 08 | Gyenes Lawrence A | buy | 51,239 |
| Feb 1, 08 | Gyenes Lawrence A | other | 200,000 |
| Nov 15, 07 | Gyenes Lawrence A | other | 200,000 |
| Oct 1, 07 | Gyenes Lawrence A | other | 0 |
| Aug 28, 07 | THERO JOHN F | other | 70,000 |
| Aug 28, 07 | THERO JOHN F | other | 70,000 |
| Feb 7, 07 | THERO JOHN F | other | 70,000 |
| Feb 1, 06 | THERO JOHN F | other | 70,000 |
| Sep 1, 05 | THERO JOHN F | other | 252 |
| May 13, 05 | THERO JOHN F | buy | 1,000 |
Our ACUS coverage
Recent articles, reports, and earnings notes.
No research on ACUS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACUS report →Similar companies
Peers in the same neighborhood.